Want to see KROS full AI Analyst Report?

Keros Therapeutics (KROS) Revenue

370 Followers

Keros Therapeutics Revenue

Keros Therapeutics had a revenue of 0.00 in the quarter ending Jun 30, 2026, with -100.00%. This bring the company's revenue in the last twelve months to 15.01M, Increased -54.75%. In the fiscal year ending Dec 31, 2025, Keros Therapeutics had annual revenue of 244.06M with 6774.96% growth.

Revenue (ttm)

15.01M

Revenue Growth

-93.55%

P/S Ratio

0.94

Revenue/Employee

$2,652,837

Employees

Market Cap

$230.39M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	244.06M	240.51M	+6,774.96%
Dec 31, 2024	3.55M	3.40M	+2,250.99%
Dec 31, 2023	151.00K	―	+∞%
Dec 31, 2022	―	-20.10M	-100.00%
Dec 31, 2021	20.10M	―	+∞%
Dec 31, 2020	―	-10.00M	-100.00%
Dec 31, 2019	10.00M	0.00	―
Dec 31, 2018	10.00M	―	―